1-11070917-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000376936.9(EXOSC10):c.2299G>A(p.Val767Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000376936.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC10 | NM_001001998.3 | c.2299G>A | p.Val767Ile | missense_variant | 21/25 | ENST00000376936.9 | NP_001001998.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC10 | ENST00000376936.9 | c.2299G>A | p.Val767Ile | missense_variant | 21/25 | 1 | NM_001001998.3 | ENSP00000366135 | P1 | |
ENST00000452378.1 | n.502C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251098Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135698
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461758Hom.: 0 Cov.: 30 AF XY: 0.0000440 AC XY: 32AN XY: 727186
GnomAD4 genome AF: 0.000433 AC: 66AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.2299G>A (p.V767I) alteration is located in exon 21 (coding exon 21) of the EXOSC10 gene. This alteration results from a G to A substitution at nucleotide position 2299, causing the valine (V) at amino acid position 767 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at